A cost-effective and focused model for HIV prevention

被引：0
作者：
Musenge, Eustasius [1 ]
机构：
[1] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, ZA-2193 Johannesburg, South Africa
来源：
LANCET HIV | 2016年 / 3卷 / 09期
关键词：
D O I：
10.1016/S2352-3018(16)30057-1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E402 / E403
页数：2
相关论文
共 9 条
  • [1] AVERTing HIV and AIDS, 2010, FUND HIV AIDS
  • [2] PEPFAR: is 90-90-90 magical thinking?
    Barnhart, Scott
    [J]. LANCET, 2016, 387 (10022) : 943 - 944
  • [3] SCIENCE AND STATISTICS
    BOX, GEP
    [J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1976, 71 (356) : 791 - 799
  • [4] Mathematical models in the evaluation of health programmes
    Garnett, Geoffrey P.
    Cousens, Simon
    Hallett, Timothy B.
    Steketee, Richard
    Walker, Neff
    [J]. LANCET, 2011, 378 (9790) : 515 - 525
  • [5] Economic evaluations to aid decision to conduct a trial
    Jefferson, T
    [J]. LANCET, 1996, 348 (9021) : 141 - 141
  • [6] McGillen JB, 2016, LANCET HIV
  • [7] An analysis of optimal resource allocation for prevention of infection with human immunodeficiency virus (HIV) in injection drug users and non-users
    Richter, A
    Brandeau, ML
    Owens, DK
    [J]. MEDICAL DECISION MAKING, 1999, 19 (02) : 167 - 179
  • [8] Williams BG, 2014, RO ELIMINATION HIV A
  • [9] Global, regional, and national levels and trends in under-5 mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Inter-agency Group for Child Mortality Estimation
    You, Danzhen
    Hug, Lucia
    Ejdemyr, Simon
    Idele, Priscila
    Hogan, Daniel
    Mathers, Colin
    Gerland, Patrick
    New, Jin Rou
    Alkema, Leontine
    [J]. LANCET, 2015, 386 (10010) : 2275 - 2286
1